Delve Bio
Healthcare Software · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
San Francisco, California, United StatesWebsite
delve.bioRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
2
3
1
1
About Delve Bio
Based in San Francisco, California, Delve Bio is a medtech company and metagenomic sequencing technologies provider.Explore more
Delve Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Delve Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Delve Bio
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Delve Bio has new funding data
Click to see if Delve Bio had a recent Job posting/layoffs
Earning: See what the market has to say on Delve Bio recently announced quarterly report
Product Launch: Get notified when Delve Bio launches new products
Delve Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Delve Bio has recently received funding, and reach out quickly before it becomes old news!
Check out if Delve Bio is spiking on competitors!
Recommended Actions
Find VP level buyers at Delve Bio
Find 3 more new buyers
Compare Similar Companies to Delve Bio
Compare insights from companies similar to Delve Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Delve Bio is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Delve Bio is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Delve Bio.
Delve Bio financials insights
Gather financial insights about Delve Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series A
$35M
Delve Bio Tech Stack
A closer look at the technologies used by Delve Bio
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Hiring Plans
Delve Bio has more open roles in Information Technology than it has had at any time in the past 12 months. Technologies mentioned include: NoSQL, Amazon AWS, Splunk, Apache Kafka, and Kubernetes with an increased focus that include Github, and CI/CD, and experience with Relational Databases, Cloud Infrastructure, Agile Management, Object Oriented Programming Language, and Agile Methodology.
Hiring Plans
Hiring Plans
Delve Bio is hiring in Sales for the first time in 12 months with an increased focus that include Account Growth.
Hiring Plans
Open Position
Delve Bio News & Media
Delve Bio Announces Launch of its Groundbreaking Genomic Infectious Disease Test, Delve Detect
BOSTON--(BUSINESS WIRE)-- #biotech--Delve Bio has launched its groundbreaking genomic infectious disease test, Delve Detect, which can identify over 68,000 pathogens in a single test.Delve Bio Presents Data Showing Metagenomic Next-Generation Sequencing (mNGS) Delivers Greater Diagnostic Yield Than Conventional Methods in Central Nervous System Infections
BOSTON--(BUSINESS WIRE)-- #biotech--Delve Bio presents data from the largest study of its kind showing the diagnostic yield of mNGS was greater than conventional test methods.Delve Bio and UCSF Publish Research Demonstrating Clinical Utility of Metagenomic Next-Generation Sequencing (mNGS) for Diagnosing Serious Neurological Infections
BOSTON--(BUSINESS WIRE)-- #biotech--Real world experience data from UCSF published in Nature Medicine shows 22% of infections were identified through metagenomic testing alone.Delve Bio Announces Partnership with Broad Clinical Labs for Metagenomic Next Generation Sequencing (mNGS)
BOSTON--(BUSINESS WIRE)-- #biotech--Delve Bio and Broad Clinical Labs announce a partnership to rapidly scale up access to metagenomic testing for patients with neurological infections.
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Delve Bio
Sign Up For FreeTo access detailed company insights
Based in San Francisco, California, Delve Bio is a medtech company and metagenomic sequencing technologies provider.... Read More
